$2.68T
Total marketcap
$46.17B
Total volume
BTC 49.83%     ETH 17.14%
Dominance

ResMed Inc. RME.F Stock

189.8 EUR {{ price }} -1.607046% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
27.88B EUR
LOW - HIGH [24H]
188.55 - 189.8 EUR
VOLUME [24H]
26 EUR
{{ volume }}
P/E Ratio
31.73
Earnings per share
5.98 EUR

ResMed Inc. Price Chart

ResMed Inc. RME.F Financial and Trading Overview

ResMed Inc. stock price 189.8 EUR
Previous Close 197.4 EUR
Open 198.15 EUR
Bid 198.2 EUR x 20000
Ask 200.2 EUR x 20000
Day's Range 198.15 - 198.15 EUR
52 Week Range 185.66 - 238 EUR
Volume 25 EUR
Avg. Volume 15 EUR
Market Cap 29.22B EUR
Beta (5Y Monthly) 0.480633
PE Ratio (TTM) 36.42463
EPS (TTM) 5.98 EUR
Forward Dividend & Yield 1.6 (0.80%)
Ex-Dividend Date May 10, 2023
1y Target Est 261.67 EUR

RME.F Valuation Measures

Enterprise Value 30.88B EUR
Trailing P/E 36.42463
Forward P/E 30.068283
PEG Ratio (5 yr expected) 2.04
Price/Sales (ttm) 7.275598
Price/Book (mrq) 7.403048
Enterprise Value/Revenue 7.691
Enterprise Value/EBITDA 24.637

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.480633
52-Week Change 7.77%
S&P500 52-Week Change 20.43%
52 Week High 238 EUR
52 Week Low 185.66 EUR
50-Day Moving Average 204.66 EUR
200-Day Moving Average 209.34 EUR

RME.F Share Statistics

Avg. Volume (3 month) 15 EUR
Avg. Daily Volume (10-Days) 17 EUR
Shares Outstanding 146.93M
Float 145.57M
Short Ratio N/A
% Held by Insiders 1.29%
% Held by Institutions 66.45%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.74
Trailing Annual Dividend Yield 0.88%
5 Year Average Dividend Yield 91.00%
Payout Ratio 0.2969
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 21.49%
Operating Margin (ttm) 27.92%
Gross Margin 57.00%
EBITDA Margin 31.21%

Management Effectiveness

Return on Assets (ttm) 12.06%
Return on Equity (ttm) 23.93%

Income Statement

Revenue (ttm) 4.02B EUR
Revenue Per Share (ttm) 27.39 EUR
Quarterly Revenue Growth (yoy) 29.19%
Gross Profit (ttm) 2.06B EUR
EBITDA 1.25B EUR
Net Income Avi to Common (ttm) 862.95M EUR
Diluted EPS (ttm) 5.44
Quarterly Earnings Growth (yoy) 29.89%

Balance Sheet

Total Cash (mrq) 240.01M EUR
Total Cash Per Share (mrq) 1.63 EUR
Total Debt (mrq) 1.72B EUR
Total Debt/Equity (mrq) 43.84 EUR
Current Ratio (mrq) 3.069
Book Value Per Share (mrq) 26.766

Cash Flow Statement

Operating Cash Flow (ttm) 535.35M EUR
Levered Free Cash Flow (ttm) 288.28M EUR

Profile of ResMed Inc.

Country Germany
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858 836 5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 8160

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RME.F stock price?

ResMed Inc. RME.F stock price today per share is 189.8 EUR.

How to purchase ResMed Inc. stock?

You can buy RME.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RME.F.

Which industry does the ResMed Inc. company belong to?

The ResMed Inc. industry is Medical Instruments & Supplies.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 146.91M.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 31.73913000 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 5.98 EUR over the trailing 12 months.

Which sector does the ResMed Inc. company belong to?

The ResMed Inc. sector is Healthcare.